White label ELPA - ClinicalTrials.eu

A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

Recruiting

3 1
Investigated Drugs:
- 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
- Bi 1015550
+15
Randomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function

Recruiting

3 1 1
Investigated Drugs:
- Azd5004
- Dapagliflozin
Effect of Lepodisiran on Coronary Plaque in Adults with Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease or High Risk for First Event

Recruiting

3 1
Investigated Diseases:
- Arteriosclerosis
Investigated Drugs:
- Ly3819469 Sodium
Metamizole Sodium Monohydrate vs Sodium Chloride for Post‑Operative Pain Relief in Adults Undergoing Elective Laparoscopic Cholecystectomy

Recruiting

3 1 1
Investigated Drugs:
- Metamizole Sodium Monohydrate
- Sodium Chloride
Phase II study of intratumoral GETACATETIDE in patients with locally advanced or metastatic adrenocortical carcinoma

Recruiting

2 1 1
Study of tasimelteon compared to placebo for treating insomnia in children

Recruiting

3 1 1
Investigated Drugs:
- Tasimelteon
Safety and Tolerability of Alisertib Sodium and Paclitaxel in Patients with Small Cell Lung Cancer (Phase 2 Study)

Recruiting

2 1 1 1
Investigated Drugs:
- Alisertib Sodium
- Paclitaxel
Phase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes

Recruiting

3 1
Investigated Diseases:
- Obesity
Investigated Drugs:
- Azd5004
Safety and Efficacy of BMS-986528 with Tocilizumab in Patients with Refractory Rheumatoid Arthritis: A Phase 1/2a Open‑Label Study

Recruiting

2 1 1 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
- Tocilizumab
Study of LY3484356 (imlunestrant) with Tamoxifen Citrate and Goserelin Acetate in Premenopausal Women with ER‑Positive, HER2‑Negative Early Breast Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Breast neoplasm
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies